Delta-like ligand 3 (DLL3) is a TAA highly expressed on the surface of tumor cells in patients with SCLC, with high expression detected in approximately 85%-94% of SCLC patients (173, 174). The gene discussed is DLL3; the disease is small cell lung carcinoma.